Innovative Medicines Initiative - Company Review
Innovative Medicines Initiative - Company ReviewSummary
Innovative Medicines Initiative (IMI) is a research association that conducts research and development of medicines for patients. The association undertakes projects such as chemical manufacturing methods for pharmaceutical industries; anti-biopharmaceutical immunization; biomarkers for enhanced vaccine immunosafety; combating bacterial resistance in Europe; and others. Its projects also include drug disease model resources; diabetes research on patient stratification; electronic health records systems for clinical research; oral biopharmaceutical tools; and others. IMI’s members include small and medium sized enterprises, biopharmaceutical companies, universities and other research organizations, patients organizations, regulatory agencies, hospitals, and other industrial partners. The association operates through other organizations to complete its projects. IMI is headquartered in Brussels, Belgium.
This comprehensive company report of Innovative Medicines Initiative provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.